Abstract

Periodontal diseases are mainly the results of infections and inflammation of the gum and bone that surround and support the teeth. In this study, the alveolar bone destruction in periodontitis is hypothesized to be treated with novel Mg-Cu alloy grafts due to their antimicrobial and osteopromotive properties. In order to study this new strategy using Mg-Cu alloy grafts as a periodontal bone substitute, the in vitro degradation and antibacterial performance were examined. The pH variation and Mg2+ and Cu2+ release of Mg-Cu alloy extracts were measured. Porphyromonas gingivalis (P. gingivalis) and Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans), two common bacteria associated with periodontal disease, were cultured in Mg-Cu alloy extracts, and bacterial survival rate was evaluated. The changes of bacterial biofilm and its structure were revealed by scanning electron microscopy (SEM) and transmission electronic microscopy (TEM), respectively. The results showed that the Mg-Cu alloy could significantly decrease the survival rates of both P. gingivalis and A. actinomycetemcomitans. Furthermore, the bacterial biofilms were completely destroyed in Mg-Cu alloy extracts, and the bacterial cell membranes were damaged, finally leading to bacterial apoptosis. These results indicate that the Mg-Cu alloy can effectively eliminate periodontal pathogens, and the use of Mg-Cu in periodontal bone grafts has a great potential to prevent infections after periodontal surgery.

Highlights

  • Periodontal disease (PD) is one of the most common diseases in humans

  • Both P. gingivalis and A. actinomycetemcomitans are capable of invading the gingival epithelial cell and produce virulence factors to disrupt host-microbial homeostasis, resulting in inflammation and bone loss

  • This study was designed to explore a potential treatment strategy for periodontal disease with novel Mg-Cu grafts which possessed the antibacterial ability against P. gingivalis and A. actinomycetemcomitans

Read more

Summary

Introduction

Periodontal disease (PD) is one of the most common diseases in humans. Approximately 750,847 million people are suffering from PD worldwide according to the global burden of disease study in 2016 [1, 2]. Many studies have proven that addition of Cu in implant material could both kill bacteria and stimulate biological responses to mesenchymal stem cells like proliferation and osteogenic differentiation [23] These properties make the Mg-Cu alloy an attractive implant material for preventing infections. A. actinomycetemcomitans is regarded as the main periodontopathogen in aggressive periodontitis and peri-implantitis [29,30,31] Both P. gingivalis and A. actinomycetemcomitans are capable of invading the gingival epithelial cell and produce virulence factors to disrupt host-microbial homeostasis, resulting in inflammation and bone loss. Periodontists rely heavily on the myriad antibiotic administration to prevent postoperative infections, leading to a worldwide antibiotic abuse problem [32] For this reason, an antibacterial bone graft which is unlikely to cause the development of drug resistance is undeniably beneficial [33, 34]. The objective of this study was to explore the antibacterial abilities of MgCu against periodontal anaerobic bacteria in order to provide more evidence for clinical application of this novel material

Material and Experimental Methods
In Vitro Antibacterial Effect Evaluation
Results
Discussion
Findings
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.